XIANWEN QIAO: Open Payments
NPI 1285972885 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 112 payments from 27 companies in 2025. Trend: 2023 $2,486 · 2024 $3,065 · 2025 $2,167
Food & beverage: $2,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $278 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $238 |
| AstraZeneca Pharmaceuticals LP | 10 | $212 |
| PFIZER INC. | 12 | $203 |
| Novo Nordisk Inc | 8 | $162 |
| Lilly USA, LLC | 7 | $146 |
| Phathom Pharmaceuticals, Inc. | 3 | $103 |
| Lundbeck LLC | 5 | $101 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| VIVUS LLC | 4 | $69 |
Products named: CAPLYTA, QULIPTA, NURTEC ODT, AIRSUPRA, REXULTI, MOUNJARO, VOQUEZNA, Wegovy.
Industry payments across PA — which companies pay providers there.
